KAI Conversations announced a strategic partnership with Syneos Health, to bring AI-driven field insights to the U.S. biopharma market. Pharmaceutical companies invest an estimated 30%?50% of revenue in field teams, yet the majority of HCP interactions fail to translate into meaningful impact. This collaboration is designed to address that gap by helping companies turn everyday field conversations into actionable insights, more effective engagement and stronger brand performance.
Through this strategic partnership, Syneos Health will embed KAI?s platform into its commercial solutions ? among the broadest in the industry ? further strengthening the Company?s ability to optimize field execution, accelerate behavior change and translate data-driven signals into measurable performance gains.
KAI?s platform, used by 10 of the top 20 global pharmaceutical companies across 15 therapeutic areas and multiple continents, analyzes conversations between field teams and healthcare professionals (HCPs). The platform delivers coaching to individual sales representatives while generating aggregated brand and customer intelligence for commercial and medical leaders. Together KAI and Syneos Health are advancing pharmaceutical commercialization by aligning AI-powered insights with integrated strategy, commercial execution and performance optimization.
